Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for refractory adult and juvenile dermatomyositis and adult polymyositis
2006-000078-65Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rituximab in dermatomyositis (DM), juvenile dermatomyositis (JDM) and polymyositis (PM) (2 arms), sponsored by Karolinska University Hospital. Started Nov 2006; status: completed.
02
Drugs
rituximab
03
Conditions
dermatomyositis (DM)juvenile dermatomyositis (JDM)polymyositis (PM)
Beyond the preview
Go deeper on 2006-000078-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000078-65.